← All sarcoma trials
Recruiting nowUp to 85 Years

Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors

Sponsor: Istituto Ortopedico Rizzoli · NCT07112989 on ClinicalTrials.gov ↗

Conditions studied

Bone and Soft Tissue TumorsBone Metastases From Solid TumorsLung Metastases

Where it's running1 site

1 international site
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Patients (male or female) diagnosed with sarcoma or with bone or lung metastases from solid tumors
* Age between 0 and 85 years
* Availability of sufficient and adequate biological material (tumor tissue and/or blood)
* Signed informed consent for biobanking (BIOTUM)
* Signed informed consent for use of tissue and blood samples in this study

Exclusion Criteria:

* Diagnosis other than sarcoma or metastases from solid tumors
* Missing signed informed consent(s)

Updated 2025-08-08 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.